Baird Financial Group, Inc. - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$259,000
-21.3%
5,677
-22.5%
0.00%0.0%
Q3 2017$329,000
-11.1%
7,327
-40.8%
0.00%
-33.3%
Q2 2017$370,000
-41.6%
12,387
-56.7%
0.00%
-40.0%
Q1 2017$634,000
+47.8%
28,583
+25.7%
0.01%
+25.0%
Q4 2016$429,000
-39.4%
22,744
-3.6%
0.00%
-33.3%
Q3 2016$708,000
+97.2%
23,601
+89.3%
0.01%
+100.0%
Q2 2016$359,000
+19.7%
12,467
+58.2%
0.00%0.0%
Q1 2016$300,000
+45.6%
7,880
+67.8%
0.00%
+50.0%
Q4 2015$206,000
-12.3%
4,695
-18.7%
0.00%0.0%
Q3 2015$235,0005,7750.00%
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders